Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion
The objective of this study was to evaluate the elimination kinetics of hemostasis-related biomarkers including the prothrombin activation fragment F1+2, thrombin-antithrombin complex (TAT), plasmin-α2-antiplasmin complex (PAP), and D-dimer in humans. Autologous serum was used as a biomarker source...
Gespeichert in:
Veröffentlicht in: | PloS one 2015-12, Vol.10 (12), p.e0145012-e0145012 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0145012 |
---|---|
container_issue | 12 |
container_start_page | e0145012 |
container_title | PloS one |
container_volume | 10 |
creator | Rühl, Heiko Berens, Christina Winterhagen, Anna Müller, Jens Oldenburg, Johannes Pötzsch, Bernd |
description | The objective of this study was to evaluate the elimination kinetics of hemostasis-related biomarkers including the prothrombin activation fragment F1+2, thrombin-antithrombin complex (TAT), plasmin-α2-antiplasmin complex (PAP), and D-dimer in humans. Autologous serum was used as a biomarker source and infused into 15 healthy volunteers. Serum was prepared from whole blood in the presence of recombinant tissue-type plasminogen activator (final concentration 20 μg/mL) to induce plasmin generation required for PAP and D-dimer formation. Serum transfusions (50 mL/30 min) were well tolerated by all subjects. Endogenous thrombin formation was not induced by serum infusions as measured using a highly sensitive oligonucleotide-based enzyme capture assay. Median peak levels (x-fold increase over baseline) of F1+2, TAT, PAP, and D-dimer of 3.7 nmol/L (28.9), 393 ng/mL (189.6), 3,829 ng/mL (7.0), and 13.4 mg/L (34.2) were achieved at the end of serum infusions. During a 48 h lasting follow-up period all biomarkers showed elimination kinetics of a two-compartment model. Median (interquartile range) terminal half-lives were 1.9 (1.3-3.6) h for F1+2, 0.7 (0.7-2.6) h for TAT, and 10.8 (8.8-11.4) h for PAP. With 15.8 (13.1-23.1) h the D-dimer half-life was about twice as long as previously estimated from radiolabeling studies in animals and small numbers of human subjects. The serum approach presented here allows label-free and simultaneous analysis of the elimination kinetics of various hemostasis-related biomarkers. Based on these data changes in biomarker levels could more precisely used to estimate the activity level of the hemostatic system. |
doi_str_mv | 10.1371/journal.pone.0145012 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1748864765</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A437465996</galeid><doaj_id>oai_doaj_org_article_a0ce7b88a52c4ce0a294915c452ebfbe</doaj_id><sourcerecordid>A437465996</sourcerecordid><originalsourceid>FETCH-LOGICAL-c758t-acfc53300bbc61017d1c3292903dda2d81b89121bc2ff67f7b0f00c9f6738c9d3</originalsourceid><addsrcrecordid>eNqNk01v1DAQhiMEoqXwDxBEQkJwyOKvJM4FaWkpXVGpUrflajnOeNeLEy92guDf42XTaoN6QDnEdp55J_OOJ0leYjTDtMQfNm7wnbSzretghjDLESaPkmNcUZIVBNHHB-uj5FkIG4RyyoviaXJEiiLnnLDjZHspa7DZuQdIv5oOeqPSZT80BkLqdHoBrQu9DCZk12BlD036ybhW-u_gQ7rolI1ot0rPsjPTgk9vw243H3pn3coNIV2CH9r0xssu6CEY1z1PnmhpA7wY3yfJ7fnnm9OL7PLqy-J0fpmpMud9JpVWOaUI1bUqMMJlgxUlFakQbRpJGo5rXmGCa0W0Lkpd1kgjpKq4plxVDT1JXu91t9YFMZoVBC4Z5wUrizwSiz3ROLkRW29iWb-Fk0b8PXB-JaSPflgQEikoa85lThRTgCSpWIVzxXICta4han0csw11C42CrvfSTkSnXzqzFiv3U7CCs9iUKPBuFPDuxwChF60JCqyVHUQf43_nKDaYViyib_5BH65upFYyFmA67WJetRMVc0ZLVuRVtUs7e4CKTwOtUfFmaRPPJwHvJwGR6eFXv5JDCGKxvP5_9urblH17wK5B2n4dnB36eGXCFGR7UHkXggd9bzJGYjcYd26I3WCIcTBi2KvDBt0H3U0C_QM-bwmE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1748864765</pqid></control><display><type>article</type><title>Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Rühl, Heiko ; Berens, Christina ; Winterhagen, Anna ; Müller, Jens ; Oldenburg, Johannes ; Pötzsch, Bernd</creator><creatorcontrib>Rühl, Heiko ; Berens, Christina ; Winterhagen, Anna ; Müller, Jens ; Oldenburg, Johannes ; Pötzsch, Bernd</creatorcontrib><description>The objective of this study was to evaluate the elimination kinetics of hemostasis-related biomarkers including the prothrombin activation fragment F1+2, thrombin-antithrombin complex (TAT), plasmin-α2-antiplasmin complex (PAP), and D-dimer in humans. Autologous serum was used as a biomarker source and infused into 15 healthy volunteers. Serum was prepared from whole blood in the presence of recombinant tissue-type plasminogen activator (final concentration 20 μg/mL) to induce plasmin generation required for PAP and D-dimer formation. Serum transfusions (50 mL/30 min) were well tolerated by all subjects. Endogenous thrombin formation was not induced by serum infusions as measured using a highly sensitive oligonucleotide-based enzyme capture assay. Median peak levels (x-fold increase over baseline) of F1+2, TAT, PAP, and D-dimer of 3.7 nmol/L (28.9), 393 ng/mL (189.6), 3,829 ng/mL (7.0), and 13.4 mg/L (34.2) were achieved at the end of serum infusions. During a 48 h lasting follow-up period all biomarkers showed elimination kinetics of a two-compartment model. Median (interquartile range) terminal half-lives were 1.9 (1.3-3.6) h for F1+2, 0.7 (0.7-2.6) h for TAT, and 10.8 (8.8-11.4) h for PAP. With 15.8 (13.1-23.1) h the D-dimer half-life was about twice as long as previously estimated from radiolabeling studies in animals and small numbers of human subjects. The serum approach presented here allows label-free and simultaneous analysis of the elimination kinetics of various hemostasis-related biomarkers. Based on these data changes in biomarker levels could more precisely used to estimate the activity level of the hemostatic system.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0145012</identifier><identifier>PMID: 26658824</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Anticoagulants ; Antigens ; Antithrombin ; Biological markers ; Biomarkers ; Biomarkers - blood ; Blood & organ donations ; Blood transfusion ; Blood Transfusion, Autologous ; Enzyme kinetics ; Enzymes ; Female ; Fibrin Fibrinogen Degradation Products - analysis ; Fibrinolysis - drug effects ; Half life ; Healthy Volunteers ; Hematology ; Hemostasis ; Hemostatics ; Hepatitis ; Hospitals ; Humans ; Kinetics ; Life assessment ; Male ; Medicine ; Middle Aged ; Oligonucleotides ; Physiological aspects ; Plasmin ; Prospective Studies ; Protein research ; Prothrombin ; Radioactive half-life ; Studies ; Thrombin ; Thrombin - analysis ; Tissue Plasminogen Activator - pharmacology ; Transfusion ; Young Adult</subject><ispartof>PloS one, 2015-12, Vol.10 (12), p.e0145012-e0145012</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Rühl et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Rühl et al 2015 Rühl et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c758t-acfc53300bbc61017d1c3292903dda2d81b89121bc2ff67f7b0f00c9f6738c9d3</citedby><cites>FETCH-LOGICAL-c758t-acfc53300bbc61017d1c3292903dda2d81b89121bc2ff67f7b0f00c9f6738c9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684386/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684386/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26658824$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rühl, Heiko</creatorcontrib><creatorcontrib>Berens, Christina</creatorcontrib><creatorcontrib>Winterhagen, Anna</creatorcontrib><creatorcontrib>Müller, Jens</creatorcontrib><creatorcontrib>Oldenburg, Johannes</creatorcontrib><creatorcontrib>Pötzsch, Bernd</creatorcontrib><title>Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The objective of this study was to evaluate the elimination kinetics of hemostasis-related biomarkers including the prothrombin activation fragment F1+2, thrombin-antithrombin complex (TAT), plasmin-α2-antiplasmin complex (PAP), and D-dimer in humans. Autologous serum was used as a biomarker source and infused into 15 healthy volunteers. Serum was prepared from whole blood in the presence of recombinant tissue-type plasminogen activator (final concentration 20 μg/mL) to induce plasmin generation required for PAP and D-dimer formation. Serum transfusions (50 mL/30 min) were well tolerated by all subjects. Endogenous thrombin formation was not induced by serum infusions as measured using a highly sensitive oligonucleotide-based enzyme capture assay. Median peak levels (x-fold increase over baseline) of F1+2, TAT, PAP, and D-dimer of 3.7 nmol/L (28.9), 393 ng/mL (189.6), 3,829 ng/mL (7.0), and 13.4 mg/L (34.2) were achieved at the end of serum infusions. During a 48 h lasting follow-up period all biomarkers showed elimination kinetics of a two-compartment model. Median (interquartile range) terminal half-lives were 1.9 (1.3-3.6) h for F1+2, 0.7 (0.7-2.6) h for TAT, and 10.8 (8.8-11.4) h for PAP. With 15.8 (13.1-23.1) h the D-dimer half-life was about twice as long as previously estimated from radiolabeling studies in animals and small numbers of human subjects. The serum approach presented here allows label-free and simultaneous analysis of the elimination kinetics of various hemostasis-related biomarkers. Based on these data changes in biomarker levels could more precisely used to estimate the activity level of the hemostatic system.</description><subject>Adult</subject><subject>Anticoagulants</subject><subject>Antigens</subject><subject>Antithrombin</subject><subject>Biological markers</subject><subject>Biomarkers</subject><subject>Biomarkers - blood</subject><subject>Blood & organ donations</subject><subject>Blood transfusion</subject><subject>Blood Transfusion, Autologous</subject><subject>Enzyme kinetics</subject><subject>Enzymes</subject><subject>Female</subject><subject>Fibrin Fibrinogen Degradation Products - analysis</subject><subject>Fibrinolysis - drug effects</subject><subject>Half life</subject><subject>Healthy Volunteers</subject><subject>Hematology</subject><subject>Hemostasis</subject><subject>Hemostatics</subject><subject>Hepatitis</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Life assessment</subject><subject>Male</subject><subject>Medicine</subject><subject>Middle Aged</subject><subject>Oligonucleotides</subject><subject>Physiological aspects</subject><subject>Plasmin</subject><subject>Prospective Studies</subject><subject>Protein research</subject><subject>Prothrombin</subject><subject>Radioactive half-life</subject><subject>Studies</subject><subject>Thrombin</subject><subject>Thrombin - analysis</subject><subject>Tissue Plasminogen Activator - pharmacology</subject><subject>Transfusion</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk01v1DAQhiMEoqXwDxBEQkJwyOKvJM4FaWkpXVGpUrflajnOeNeLEy92guDf42XTaoN6QDnEdp55J_OOJ0leYjTDtMQfNm7wnbSzretghjDLESaPkmNcUZIVBNHHB-uj5FkIG4RyyoviaXJEiiLnnLDjZHspa7DZuQdIv5oOeqPSZT80BkLqdHoBrQu9DCZk12BlD036ybhW-u_gQ7rolI1ot0rPsjPTgk9vw243H3pn3coNIV2CH9r0xssu6CEY1z1PnmhpA7wY3yfJ7fnnm9OL7PLqy-J0fpmpMud9JpVWOaUI1bUqMMJlgxUlFakQbRpJGo5rXmGCa0W0Lkpd1kgjpKq4plxVDT1JXu91t9YFMZoVBC4Z5wUrizwSiz3ROLkRW29iWb-Fk0b8PXB-JaSPflgQEikoa85lThRTgCSpWIVzxXICta4han0csw11C42CrvfSTkSnXzqzFiv3U7CCs9iUKPBuFPDuxwChF60JCqyVHUQf43_nKDaYViyib_5BH65upFYyFmA67WJetRMVc0ZLVuRVtUs7e4CKTwOtUfFmaRPPJwHvJwGR6eFXv5JDCGKxvP5_9urblH17wK5B2n4dnB36eGXCFGR7UHkXggd9bzJGYjcYd26I3WCIcTBi2KvDBt0H3U0C_QM-bwmE</recordid><startdate>20151214</startdate><enddate>20151214</enddate><creator>Rühl, Heiko</creator><creator>Berens, Christina</creator><creator>Winterhagen, Anna</creator><creator>Müller, Jens</creator><creator>Oldenburg, Johannes</creator><creator>Pötzsch, Bernd</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20151214</creationdate><title>Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion</title><author>Rühl, Heiko ; Berens, Christina ; Winterhagen, Anna ; Müller, Jens ; Oldenburg, Johannes ; Pötzsch, Bernd</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c758t-acfc53300bbc61017d1c3292903dda2d81b89121bc2ff67f7b0f00c9f6738c9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Anticoagulants</topic><topic>Antigens</topic><topic>Antithrombin</topic><topic>Biological markers</topic><topic>Biomarkers</topic><topic>Biomarkers - blood</topic><topic>Blood & organ donations</topic><topic>Blood transfusion</topic><topic>Blood Transfusion, Autologous</topic><topic>Enzyme kinetics</topic><topic>Enzymes</topic><topic>Female</topic><topic>Fibrin Fibrinogen Degradation Products - analysis</topic><topic>Fibrinolysis - drug effects</topic><topic>Half life</topic><topic>Healthy Volunteers</topic><topic>Hematology</topic><topic>Hemostasis</topic><topic>Hemostatics</topic><topic>Hepatitis</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Life assessment</topic><topic>Male</topic><topic>Medicine</topic><topic>Middle Aged</topic><topic>Oligonucleotides</topic><topic>Physiological aspects</topic><topic>Plasmin</topic><topic>Prospective Studies</topic><topic>Protein research</topic><topic>Prothrombin</topic><topic>Radioactive half-life</topic><topic>Studies</topic><topic>Thrombin</topic><topic>Thrombin - analysis</topic><topic>Tissue Plasminogen Activator - pharmacology</topic><topic>Transfusion</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rühl, Heiko</creatorcontrib><creatorcontrib>Berens, Christina</creatorcontrib><creatorcontrib>Winterhagen, Anna</creatorcontrib><creatorcontrib>Müller, Jens</creatorcontrib><creatorcontrib>Oldenburg, Johannes</creatorcontrib><creatorcontrib>Pötzsch, Bernd</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rühl, Heiko</au><au>Berens, Christina</au><au>Winterhagen, Anna</au><au>Müller, Jens</au><au>Oldenburg, Johannes</au><au>Pötzsch, Bernd</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-12-14</date><risdate>2015</risdate><volume>10</volume><issue>12</issue><spage>e0145012</spage><epage>e0145012</epage><pages>e0145012-e0145012</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The objective of this study was to evaluate the elimination kinetics of hemostasis-related biomarkers including the prothrombin activation fragment F1+2, thrombin-antithrombin complex (TAT), plasmin-α2-antiplasmin complex (PAP), and D-dimer in humans. Autologous serum was used as a biomarker source and infused into 15 healthy volunteers. Serum was prepared from whole blood in the presence of recombinant tissue-type plasminogen activator (final concentration 20 μg/mL) to induce plasmin generation required for PAP and D-dimer formation. Serum transfusions (50 mL/30 min) were well tolerated by all subjects. Endogenous thrombin formation was not induced by serum infusions as measured using a highly sensitive oligonucleotide-based enzyme capture assay. Median peak levels (x-fold increase over baseline) of F1+2, TAT, PAP, and D-dimer of 3.7 nmol/L (28.9), 393 ng/mL (189.6), 3,829 ng/mL (7.0), and 13.4 mg/L (34.2) were achieved at the end of serum infusions. During a 48 h lasting follow-up period all biomarkers showed elimination kinetics of a two-compartment model. Median (interquartile range) terminal half-lives were 1.9 (1.3-3.6) h for F1+2, 0.7 (0.7-2.6) h for TAT, and 10.8 (8.8-11.4) h for PAP. With 15.8 (13.1-23.1) h the D-dimer half-life was about twice as long as previously estimated from radiolabeling studies in animals and small numbers of human subjects. The serum approach presented here allows label-free and simultaneous analysis of the elimination kinetics of various hemostasis-related biomarkers. Based on these data changes in biomarker levels could more precisely used to estimate the activity level of the hemostatic system.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>26658824</pmid><doi>10.1371/journal.pone.0145012</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2015-12, Vol.10 (12), p.e0145012-e0145012 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1748864765 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
subjects | Adult Anticoagulants Antigens Antithrombin Biological markers Biomarkers Biomarkers - blood Blood & organ donations Blood transfusion Blood Transfusion, Autologous Enzyme kinetics Enzymes Female Fibrin Fibrinogen Degradation Products - analysis Fibrinolysis - drug effects Half life Healthy Volunteers Hematology Hemostasis Hemostatics Hepatitis Hospitals Humans Kinetics Life assessment Male Medicine Middle Aged Oligonucleotides Physiological aspects Plasmin Prospective Studies Protein research Prothrombin Radioactive half-life Studies Thrombin Thrombin - analysis Tissue Plasminogen Activator - pharmacology Transfusion Young Adult |
title | Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T01%3A56%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Label-Free%20Kinetic%20Studies%20of%20Hemostasis-Related%20Biomarkers%20Including%20D-Dimer%20Using%20Autologous%20Serum%20Transfusion&rft.jtitle=PloS%20one&rft.au=R%C3%BChl,%20Heiko&rft.date=2015-12-14&rft.volume=10&rft.issue=12&rft.spage=e0145012&rft.epage=e0145012&rft.pages=e0145012-e0145012&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0145012&rft_dat=%3Cgale_plos_%3EA437465996%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1748864765&rft_id=info:pmid/26658824&rft_galeid=A437465996&rft_doaj_id=oai_doaj_org_article_a0ce7b88a52c4ce0a294915c452ebfbe&rfr_iscdi=true |